Sandrine Thouroude

Sandrine Thouroude

Auto-generated profile, based on publicly available information

Sandrine Thouroude

Institut de biologie Paris-Seine

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2024 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
YPYevheniia Porozhan
Yevheniia Porozhan
MCMikkel Carstensen
Mikkel Carstensen
STSandrine Thouroude
Sandrine Thouroude
MCMickaël Costallat
Mickaël Costallat
CRChristophe Rachez
Christophe Rachez
Christian MuchardtChristian Muchardt
Christian Muchardt
HP1α/CBX5 is an epigenetic regulator with a suspected role in multiple sclerosis (MS). Here, using high-depth RNA sequencing on monocytes, we identified a subset of MS patients with reduced CBX5 expression, correlating with progressive stages of the disease and extensive transcriptomic alterations. Examination of rare non-coding RNA species in these patients revealed impaired maturation/degradation of U snRNAs and enhancer RNAs, indicative of reduced activity of the Integrator, a complex with suspected links to increased MS risk. At protein-coding genes, compromised Integrator activity manifested in reduced pre-mRNA splicing efficiency and altered expression of genes regulated by RNA polymerase II pause–release. Inactivation of Cbx5 in the mouse mirrored most of these transcriptional defects and resulted in hypersensitivity to experimental autoimmune encephalomyelitis. Collectively, our observations suggested a major contribution of the Integrator complex in safeguarding against transcriptional anomalies characteristic of MS, with HP1α/CBX5 emerging as an unexpected regulator of this complex’s activity. These findings bring novel insights into the transcriptional aspects of MS and provide potential new criteria for patient stratification.